To investigate the impact of chronic heart failure on pulmonary function in
heart transplant recipients, pulmonary function was evaluated in 41 consec
utive patients (mean age 43 years, range 15-57 years) before and 6 months a
fter successful heart transplantation. The pulmonary function tests include
d measurements of forced vital capacity [FVC], forced expiratory volume in
1.s [FEV1], FEV1/FVC ratio, total lung capacity [TLC], and diffusion capaci
ty for carbon monoxide [T-LCO] and KCO [T-LCO per 1 alveolar volume].
Compared to pretransplant values, spirometry after transplantation revealed
modest improvements in FVC (from 77 +/- 16 to 88 +/- 21% of predicted [%pr
ed]; p < 0.001) and FEV1 (from 75 +/- 16 to 85 +/- 22%pred; p < 0.001), whe
reas the FEV1/FVC ratio was unchanged (81% +/- 11 and 80% +/- 10; p = NS).
A slight but statistically significant increase in TLC (from 78 +/- 15 to 8
6 +/- 18%pred, p < 0.001) was also observed. Prior to transplantation the m
ean T-LCO was 76 +/- 17%pred; 7 of the patients had a T-LCO below 60%pred (
mean 51% pred). In 33 of the 41 patients a reduction in T-LCO was observed
after transplantation; for all 41 patients the mean fall in T-LCO was 14% o
f the predicted value (SD 12%pred) (p < 0.0001). Likewise, a significant re
duction in KCO was noted (p < 0.0001). Multiple regression analysis reveale
d that high pretransplant T-LCO %pred (p = 0.02) and FVC %pred (p = 0.04) w
ere associated with a less favorable outcome concerning posttransplant T-LC
O %pred.
Although normalization of FEV1, FVC and TLC can be anticipated after correc
tion of severe chronic left ventricular failure by heart transplantation, t
he pronounced concomitant decline in diffusion capacity observed in this st
udy may be explained by underlying pulmonary disease caused by factors othe
r than long-standing heart failure. Our findings support the notion that pu
lmonary function abnormalities attributable to chronic heart failure should
not preclude consideration for heart transplantation.